Please use this identifier to cite or link to this item: https://repository.iimb.ac.in/handle/2074/17850
Title: Scope of an anti-epileptic drug (Vol.1) and ensamycin
Authors: Ganguli, Sujit 
Keywords: Pharmaceutical industry;Drugs;Anti-epiletic drug;Lennox Gastaut Syndrome;Clinical trials of felbamate
Issue Date: 1993
Publisher: Indian Institute of Management Bangalore
Series/Report no.: PGP_SP_N3_029
Abstract: The study conducted showed that the average number of patients treated by the Neurologists is about 30 per week. and the average number for the Paediatricians and Physicians is about 6 per week. According to the doctors about 21% of the patients get cured, 71% get controlled and about 8 % of the patients are refractory to treatment. The most common types of Epilepsies are GRAND HOL and ABSENCE type of Epilepsies. The commonly used drugs to treat Epileptic patients are CARBAMAZEPINE, SODIUM VALPROATE, PHENYTOIN, AND PHENOBARBITONE. All these drugs produce side effects. The common side effects are sedation, drowsiness, ataxia, cognitive dysfunction, etc. Some drugs even produce very dangerous side effects at times. Like liver toxicity and bone marrow depression.
URI: https://repository.iimb.ac.in/handle/2074/17850
Appears in Collections:1990-1995

Files in This Item:
File SizeFormat 
PGP_SP_N3_029.pdf682.91 kBAdobe PDFView/Open    Request a copy
Show full item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.